Indication

Nemaline Myopathy

1 clinical trial

1 product

Clinical trial

COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral Salbutamol

Status: , Estimated PCD: 2025-12-31

Product